Please login to the form below
22
Revenue 2017Baxter
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Baxter's 2013 sales performance.
NHS England to roll out continuous glucose monitors to all those with type 1 diabetes
Karen Baxter, vice president, UK and Ireland, Benelux, France and Spain at Dexcom, also commented: “The addition of Dexcom ONE to the NHS England drug tariff is enormous progress towards improving
Value-Based Procurement: Why is Now the Right Time? Why is Now the Right Time?
Most importantly, it has furthered Baxter’s commercial objectives and generated conversations with ten NHS Trusts. ... This project by WA Communications and Baxter was solid, a tough subject and well-articulated.
Finalists 2022
by WA Communications. for Baxter Healthcare Ltd. FAST Heroes. by We are Twelve.
Moderna seeks full FDA approval for its COVID-19 vaccine
In the US, the company is collaborating with Lonza Portsmouth for drug substance production and further partnerships with Catalent, Baxter BioPharma Solutions, Sanofi and Thermo Fisher Scientific for fill/finish services.
Bedrock announces a number of new hires
Barton has previous sales and marketing experience gained from roles at AstraZeneca, Baxter, Abbott, AbbVie and Novartis.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- MIT researchers develop AI model to detect future lung cancer risk
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- Fishawack Health welcomes Mario Muredda as its new President of Marketing
- Pharmaceutical Marketing Strategies For The Digital Age
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- Roche’s Polivy recommended by NICE for lymphoma therapy
- A bundle of nerves
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
PMHub
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to...
Latest intelligence
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
- The challenges of identifying rare diseases
- With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
- 5 ways we’re enhancing our services to support our clients in 2023
- Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
